Immunogenetics Research Group, Department of Immunology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
Laboratory of Cellular and Molecular Biology, College of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
Int J Cancer. 2020 Sep 1;147(5):1397-1404. doi: 10.1002/ijc.32992. Epub 2020 Apr 9.
In our study, 1,105 cases of nasopharyngeal carcinoma (NPC) and 1,430 normal controls recruited from Hunan province, southern China were typed for human leukocyte antigen (HLA)-B locus by Sanger sequencing exons 2-4. Besides confirming the NPC association with HLA-B46:01 allele, HLA-A02:07-B46:01 and HLA-A33:03-B58:01 haplotypes (all positive), and HLA-B13 lineage (negative), all of which were relatively common, strong negative associations were observed for five low-frequency and rare alleles or lineages, including HLA-B07, -B27:04, -B39, -B51:02 and -B55:02, with odds ratio (OR) ranging from 0.16 to 0.3 (all p < 0.05). These strong protective associations were independent of linkage disequilibrium (LD) between HLA-A and HLA-B loci. Further analysis indicated a single amino acid change from histidine to tyrosine at residue 171 is probably crucial for the mutant allele, HLA-B51:02, to mediate resistance to NPC. A subset of NPC cases (n = 821) and normal controls (n = 1,035) were tested for antivirus capsid antigen immunoglobulin A (anti-VCA IgA), which differed drastically between the two groups [67.7% vs. 5.5%, OR (95% confidence interval) = 36 (26.55-48.81), p < 0.0001]. HLA-B allelic variation did not associate with seropositivity for anti-VCA IgA in either group. Results from our study show, more clearly than previously, the existence of a cluster of low-frequency and rare HLA-B variants conferring low, or very low risk to NPC, a phenomenon not observed in other ethnic groups. Our data shed new insights into genetic susceptibility to NPC in southern Chinese populations. Future independent studies are warranted to replicate the findings reported in our study.
在我们的研究中,通过 Sanger 测序外显子 2-4,对来自中国南方湖南省的 1105 例鼻咽癌 (NPC) 病例和 1430 例正常对照者进行了人类白细胞抗原 (HLA)-B 基因座分型。除了证实 NPC 与 HLA-B46:01 等位基因相关外,HLA-A02:07-B46:01 和 HLA-A33:03-B58:01 单倍型(均为阳性)以及 HLA-B13 谱系(阴性)外,我们还观察到五个低频和罕见等位基因或谱系(HLA-B07、-B27:04、-B39、-B51:02 和 -B55:02)与 NPC 的负相关关联较强,其比值比 (OR) 范围为 0.16 至 0.3(均 p<0.05)。这些强保护性关联与 HLA-A 和 HLA-B 基因座之间的连锁不平衡 (LD) 无关。进一步的分析表明,残基 171 从组氨酸到酪氨酸的单个氨基酸变化可能是突变等位基因 HLA-B51:02 介导对 NPC 抗性的关键。对一组 NPC 病例 (n=821) 和正常对照者 (n=1035) 进行了抗病毒壳抗原免疫球蛋白 A (抗-VCA IgA) 检测,两组之间差异显著 [67.7% vs. 5.5%,比值比 (95%置信区间) = 36 (26.55-48.81),p<0.0001]。在两组中,HLA-B 等位基因变异与抗-VCA IgA 的血清阳性均无关。本研究的结果比以往更清楚地表明,存在一群低频和罕见的 HLA-B 变异体,它们使 NPC 的风险降低或非常低,这在其他族群中并未观察到。我们的数据为中国南方人群 NPC 的遗传易感性提供了新的见解。需要进一步的独立研究来复制我们研究中报告的结果。